WELCH DAVID E 4
4 · AspenBio Pharma, Inc. · Filed Dec 13, 2012
Insider Transaction Report
Form 4
WELCH DAVID E
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-12-11+33,340→ 33,340 totalExercise: $2.10Exp: 2012-12-11→ Common Stock (33,340 underlying)
Footnotes (1)
- [F1]The option to purchase 33,340 shares of common stock shall become exercisable in full on December 11, 2013.